Gastroenterology clinical trials recruiting in California

118 recruiting gastroenterology trials match in California. Showing 20.

• LY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 2 · Eli Lilly and Company · Anaheim, California

• Precise Infliximab Exposure and Pharmacodynamic ControlRecruiting

  Phase 2 / Phase 3 · Children's Hospital Medical Center, Cincinnati · Los Angeles, California

• Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentRecruiting

  N/A · Fresenius Kabi · Fountain Valley, California

• LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisRecruiting

  Phase 3 · Boehringer Ingelheim · Canoga Park, California

• Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASHRecruiting

  Phase 2 · Madrigal Pharmaceuticals, Inc. · La Jolla, California

• Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy ProjectRecruiting

  N/A · University of California, San Diego · La Jolla, California

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Hoffmann-La Roche · Lancaster, California

• Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's DiseaseRecruiting

  Phase 2 · AbbVie · Coronado, California

• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 / Phase 3 · Janssen Research & Development, LLC · Anaheim, California

• A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisRecruiting

  Phase 2 · Spyre Therapeutics, Inc. · Canoga Park, California

• A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative ColitisRecruiting

  Phase 2 · Sanofi · Escondido, California

• Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United StatesRecruiting

  Phase 2 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · La Jolla, California

• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 3 · Sanofi · Arcadia, California

• Transpyloric Versus Gastric Feeding in Bronchopulmonary DysplasiaRecruiting

  N/A · Children's Hospital of Philadelphia · Palo Alto, California

• Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 3 · Vanda Pharmaceuticals · Chula Vista, California

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 · Abivax S.A. · Murrieta, California

• A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative ColitisRecruiting

  Phase 2 / Phase 3 · Bristol-Myers Squibb · Loma Linda, California

• Accurate Point of Care Liver Disease Diagnostics (Phase 2)Recruiting

  N/A · University of California, San Diego · La Jolla, California

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 3 · Hoffmann-La Roche · Apple Valley, California

• The Influence of a Fasting Mimicking Diet on Ulcerative ColitisRecruiting

  N/A · Stanford University · Palo Alto, California

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.